TherapeuticsMD (TXMD) Non-Current Assets (2010 - 2026)

TherapeuticsMD's Non-Current Assets history runs 17 years deep, the most recent figure standing at $22.3 million for Q1 2026.

• Quarterly Non-Current Assets fell 13.24% year-over-year to $22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.7 million (down 12.27% YoY) and the FY2025 annual result came in at $23.2 million, down 12.62% from the prior year.
• Non-Current Assets was $22.3 million for Q1 2026 at TherapeuticsMD, down from $23.2 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $49.0 million in Q1 2022 and bottomed at $22.3 million in Q1 2026.
• A 5-year average of $32.1 million and a median of $30.6 million in 2024 frame the typical range for Non-Current Assets.
• Peak annual rise in Non-Current Assets reached 6.33% in 2022, while the deepest fall reached 29.79% in 2022.
• TherapeuticsMD's Non-Current Assets stood at $35.1 million in 2022, then dropped by 10.24% to $31.5 million in 2023, then declined by 15.71% to $26.6 million in 2024, then slipped by 12.62% to $23.2 million in 2025, then declined by 3.85% to $22.3 million in 2026.
• Business Quant data shows TXMD's Non-Current Assets at $22.3 million in Q1 2026, $23.2 million in Q4 2025, and $24.2 million in Q3 2025.